新诊断头颈癌患者治疗前神经认知功能与自报症状:与非癌症队列比较
研究比较80例治疗前头颈癌患者与40例非癌症对照的神经认知功能(NCF)及自报认知、疲劳和情绪,并检测器官储备、激素和细胞因子。患者认知功能障碍、疲劳和焦虑症状更重,但NCF表现与对照相当;按已发表常模比较,两组表现异常率均高(患者9/80,对照3/40)。结论提示治疗前患者自报认知困扰,但表现异常频率高且假阳性常见,纳入非癌症对照至关重要。
要点
- 治疗前头颈癌患者自报认知功能障碍、疲劳和焦虑症状较非癌症对照更重。
- 两组神经认知功能表现相当,按常模比较表现异常率均高(患者9/80,对照3/40)。
- 仅用常模数据比较可能误读神经心理测试结果,需纳入非癌症对照。
核心结论
- 治疗前头颈癌患者自报认知困扰更重,但神经认知功能表现与对照相当。
- 神经心理测试表现异常频率高,假阳性并不少见,纳入非癌症对照至关重要。
研究设计与样本
- 研究纳入80例治疗前新诊断头颈癌患者和40例非癌症对照。
- 评估神经认知功能(NCF)及自报认知、疲劳和情绪,并采集血样检测器官储备、激素和细胞因子。
主要发现
- 患者认知功能障碍、疲劳和焦虑症状较对照更重。
- 患者与对照的NCF表现相当。
- 按已发表常模比较,两组表现异常率均高:患者9/80,对照3/40。
关键数值与推荐
- 表现异常范围:患者9/80,对照3/40。
临床怎么用
- 解读头颈癌患者治疗前神经心理测试结果时,应考虑到假阳性可能,避免仅依据常模误判。
- 自报认知困扰可作为症状评估的一部分,但需结合客观NCF表现综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Newly diagnosed patients with head and neck cancer may be at risk for impaired neurocognitive function (NCF) due to disease, treatment, and lifestyle factors. METHODS: Eighty pretreatment patients with head and neck cancer and 40 control patients without cancer completed assessment of NCF and self-reported cognition, fatigue, and mood. Blood samples to evaluate organ reserves, hormones, and cytokines were collected. RESULTS: Patients experienced worse symptoms of cognitive dysfunction, fatigue, and anxiety than controls. In contrast, NCF was equivalent for patients and controls. Using published norms as comparison, groups had similar high rates of impairment in performance (9/80 patients and 3/40 controls scored in the abnormal range). CONCLUSION: Pretreatment patients with head and neck cancer reported cognitive disturbance. The frequency of impaired performance, albeit high, was consistent with the literature demonstrating false-positive "abnormal" neuropsychological test performance is not uncommon. Inclusion of a noncancer patient control cohort is essential because using solely normative data as a comparison may foster erroneous interpretation.
引用
- Bernstein LJ, Pond GR, Gan HK, et al. Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort. Head Neck. 2018. PMID: 29667262. doi:10.1002/hed.25198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。